Telesis Bio shares are trading lower after the company announced that it has notified the Nasdaq Stock Market of its decision to delist.
Portfolio Pulse from Benzinga Newsdesk
Telesis Bio has announced its decision to delist from the Nasdaq Stock Market, leading to a decline in its share price.
September 10, 2024 | 8:35 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Telesis Bio has decided to delist from the Nasdaq Stock Market, causing its shares to trade lower.
The decision to delist from Nasdaq is a significant move that typically leads to a decrease in stock price due to reduced liquidity and investor access. This has resulted in a negative short-term impact on TBIO's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100